PwC Behind the Numbers 2027: Medical Cost Trend Hits 9%
Commercial medical cost trend is projected to reach 9% in 2027 — the highest in 17 years — according to PwC’s Behind the Numbers 2027 report. Five inflators…
Financial planning, analysis, budgeting, forecasting, and unit economics.
Commercial medical cost trend is projected to reach 9% in 2027 — the highest in 17 years — according to PwC’s Behind the Numbers 2027 report. Five inflators…
Medicare Advantage (MA) already offers substantially greater price predictability than traditional Medicare — MA enrollees saw monthly out-of-pocket costs 18–24% lower than traditional Medicare from 2014 to 2019,…
Independent orthopedic practices across the U.S. are reducing Medicare exposure — and in some cases dropping it entirely — as reimbursement rates fail to keep pace with rising…
Health systems in 2026 are applying a “buy, sell, or fight” calculus to market strategy — acquiring where they can build density, divesting where they’re subscale, and competing…
Enhanced ACA premium subsidies expired at the end of 2025, and major health systems are now reporting the financial fallout in Q1 earnings. HCA Healthcare saw a 15%…
Over 80 million Americans lack dental insurance — and many are already patients at DSO-affiliated practices. Dental membership programs convert uninsured patients into recurring revenue by bundling preventive…
Becker’s Hospital Review is tracking 21 health systems that have terminated or are exiting Medicare Advantage contracts in 2026, citing persistent prior authorization denials and inadequate reimbursement from…
Universal Health Services reported Q1 2026 volume declines in both its acute care and behavioral health divisions, driven by a weak respiratory season and winter storms. Despite the…
Both health systems and health insurers privately acknowledge that AI ambient scribes are driving up healthcare costs — though they frame the issue very differently. Providers argue scribes…
PwC’s 2026 healthcare investment outlook projects a more consistent year for private equity deal activity, supported by lower interest rates, available dry powder, and LP pressure for liquidity…